TwinBeech Capital’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
TwinBeech Capital's BCAX Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 30,456 shares worth $567K. The stake represents 0.13% of the portfolio and ranks #212 among its holdings.
169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.
- TwinBeech Capital held 30,456 shares of Bicara Therapeutics worth $567K as of Q3 2026.
- Bicara Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Bicara Therapeutics made up 0.13% of TwinBeech Capital's portfolio in Q3 2026, its #212 holding.
- 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.